跳至主要内容
临床试验/EUCTR2008-007086-23-IT
EUCTR2008-007086-23-IT进行中(未招募)不适用

Whole lung lavage followed by inhaled Sargramostim in the treatment of autoimmune pulmonary alveolar proteinosis. - WLL/inhaled GM-CSF in autoimmune PAP

OSPEDALE POLICLINICO S. MATTEO0 个研究点开始时间: 2009年1月27日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • autoimmune PAP diagnosis; age >= 18 years; persistant or progressive respiratory failure (PaO2 < 60 mmHg) or latent respiratory failure (SatO2 < 90% or desaturation > 5% in Bruce`s test) or persistant pulmonary TC abnormalities (intensity score >=3) (reasidual disease treated group)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • non autoimmune PAP; contraindications to WLL; contraindication to GM-CSF; pregnancy; refusal to the use of contraceptive methods during the study period; contraindications to the use of inhaled medicines.

研究者

发起方
OSPEDALE POLICLINICO S. MATTEO

相似试验